About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Tamoxifen Citrate
- Company
- National Cancer Institute (NCI)
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 46 recruiting
Efficacy results: Not yet reported
46 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026
Find a Clinical Trial Near Me
See recruiting studies for Tamoxifen Citrate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01788839
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Memorial Sloan Kettering Cancer Center 475 participants Est. completion 2027-02 7 sitesOther conditions: Breast Cancer, Lymphoma, Hodgkin's LymphomaView official trial listing → -
Recruiting NCT NCT04293796
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)
Not yet reported N.N. Petrov National Medical Research Center of Oncology 60 participants Est. completion 2028-12-10 1 site Stand-aloneOther conditions: Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBView official trial listing → -
Recruiting NCT NCT04312399
Hormone Replacement Trial Against ALzheimers' Disease
Not yet reported University Hospital, Ghent 600 participants Est. completion 2028-12-31 1 siteOther conditions: Postmenopausal Symptoms, Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT04476485
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
Shengjing Hospital 1000 participants Est. completion 2026-12-31 12 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Not yet reported Pfizer 430 participants Est. completion 2029-10-07 39 sites Stand-aloneObstructive sleep apnea Other conditions: Prostate Cancer, Advanced Breast Cancer, NSCLC (Non-small Cell Lung Cancer), Colorectal CancerView official trial listing → -
Recruiting NCT NCT04740697
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Not yet reported Institut Claudius Regaud 200 participants Est. completion 2028-02 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04765098
Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
Not yet reported AHS Cancer Control Alberta 60 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: Glioblastoma MultiformeView official trial listing → -
Recruiting NCT NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Not yet reported Royal Marsden NHS Foundation Trust 1100 participants Est. completion 2030-09-01 49 sitesOther conditions: ER+ Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05056857
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
M.D. Anderson Cancer Center 290 participants Est. completion 2026-10-31 1 siteOther conditions: Breast CarcinomaView official trial listing → -
Recruiting NCT NCT05306041
Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer
Not yet reported GBG Forschungs GmbH 170 participants Est. completion 2027-03 62 sites Stand-aloneOther conditions: HER2-positive Breast CancerView official trial listing → -
Recruiting NCT NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sites Stand-aloneOther conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast CancerView official trial listing → -
Recruiting NCT NCT05512364
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 220 participants Est. completion 2035-11-01 113 sitesOther conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast CancerView official trial listing → -
Recruiting NCT NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Not yet reported, Not yet reported Eli Lilly and Company 880 participants Est. completion 2030-07 65 sites Stand-aloneOther conditions: Breast Cancer, Solid Tumors, AdultView official trial listing → -
Recruiting NCT NCT05878314
Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer
University Hospital Tuebingen 504 participants Est. completion 2035-04 1 siteOther conditions: Hormone Receptor Positive HER-2 Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05891093
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Not yet reported Fudan University 766 participants Est. completion 2031-05-31 15 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT05941520
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Not yet reported National Cancer Institute (NCI) 80 participants Est. completion 2028-09-01 4 sitesOther conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In SituView official trial listing → -
Recruiting NCT NCT05982093
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 96 participants Est. completion 2026-12 15 sitesOther conditions: Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Premenopausal Breast CancerView official trial listing → -
Recruiting NCT NCT06075953
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Not yet reported QuantumLeap Healthcare Collaborative 400 participants Est. completion 2033-11 31 sites Stand-aloneOther conditions: Ductal Carcinoma in SituView official trial listing → -
Recruiting NCT NCT06195306
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2028-01-01 3 sites Stand-aloneOther conditions: Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In SituView official trial listing → -
Recruiting NCT NCT06218303
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Not yet reported Finn, Olivera, PhD 50 participants Est. completion 2029-12-31 1 site Stand-aloneOther conditions: Ductal Carcinoma in SituView official trial listing → -
Recruiting NCT NCT06320990
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
Not yet reported University of Nebraska 15 participants Est. completion 2029-05 1 site Stand-aloneOther conditions: Pancreatic Cyst, Pancreatic Mucinous Cystic NeoplasmView official trial listing → -
Recruiting NCT NCT06348134
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Not yet reported University of Chicago 74 participants Est. completion 2036-07-01 4 sites Stand-aloneOther conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2-positive Breast Cancer, Breast CancerView official trial listing → -
Recruiting NCT NCT06361940
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Not yet reported Medical College of Wisconsin 185 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT06369285
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Not yet reported Puma Biotechnology, Inc. 225 participants Est. completion 2029-06-30 53 sites Stand-aloneOther conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast CancerView official trial listing → -
Recruiting NCT NCT06434064
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
Not yet reported Roswell Park Cancer Institute 30 participants Est. completion 2028-11-30 1 site Stand-aloneOther conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Unresectable Triple-Negative Breast Carcinoma, Metastatic Triple-Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT06507618
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Not yet reported University of Virginia 354 participants Est. completion 2034-03-01 6 sites Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Recruiting NCT NCT06548919
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
SciClone Pharmaceuticals 450 participants Est. completion 2027-12-31 1 siteOther conditions: ESR1 Gene Mutation, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT06590857
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Not yet reported, Not yet reported RayzeBio, Inc. 64 participants Est. completion 2033-11 32 sites Stand-aloneOther conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast CancerView official trial listing → -
Recruiting NCT NCT06914674
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Not yet reported Fudan University 30 participants Est. completion 2028-02-28 1 site Stand-aloneOther conditions: Pancreatic NeoplasmsView official trial listing → -
Recruiting NCT NCT06917313
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Not yet reported Yale University 92 participants Est. completion 2028-03 2 sitesOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Recruiting NCT NCT06942039
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Not yet reported C17 Council 15 participants Est. completion 2032-12-31 13 sites Stand-aloneOther conditions: CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, Medulloblastoma, Childhood, Medulloblastoma, Group 3, Medulloblastoma, Group 4, Pineoblastoma, Neuroblastoma, Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Abundant Neuropil and True Rosettes, Ependymoblastoma, Medulloepithelioma, CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, NosView official trial listing → -
Recruiting NCT NCT06944145
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Not yet reported Beth Israel Deaconess Medical Center 242 participants Est. completion 2030-08-31 1 siteOther conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Track SymptomsView official trial listing → -
Recruiting NCT NCT06979596
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Not yet reported Merck Sharp & Dohme LLC 250 participants Est. completion 2027-11-04 60 sites Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT07019363
CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
Not yet reported Fudan University 1903 participants Est. completion 2033-04-15 1 siteOther conditions: Breast Cancer, Adjuvant TherapyView official trial listing → -
Recruiting NCT NCT07071038
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
Not yet reported Dartmouth-Hitchcock Medical Center 62 participants Est. completion 2027-08-05 1 siteOther conditions: Breast Cancer, Adjuvant Treatment, Early Stage Breast CancerView official trial listing → -
Recruiting NCT NCT07190443
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Not yet reported Japanese Foundation for Cancer Research 290 participants Est. completion 2035-02-06 1 site Stand-aloneOther conditions: Breast Cancer, Locoregional Recurrence, Abemaciclib, Endocrine TherapyView official trial listing → -
Recruiting NCT NCT07289035
Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 35 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Cystic Fibrosis - CompleteView official trial listing → -
Recruiting NCT NCT07349069
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
Not yet reported Shandong Suncadia Medicine Co., Ltd. 5500 participants Est. completion 2034-01 2 sitesOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07470606
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Not yet reported The University of Texas Health Science Center at San Antonio 108 participants Est. completion 2031-07 1 siteOther conditions: Brain TumorView official trial listing → -
Recruiting NCT NCT07483307
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 176 participants Est. completion 2030-03-13 7 sites Stand-aloneOther conditions: Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER+ Breast Cancer, Lobular Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07502820
The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER
Not yet reported Karolinska Institutet 1100 participants Est. completion 2036-08 4 sites Stand-aloneOther conditions: Breast Cancer, Adjuvant Drug TherapyView official trial listing → -
Recruiting NCT NCT07581834
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Not yet reported Fujian Cancer Hospital 2000 participants Est. completion 2032-06-30 2 sites Stand-aloneOther conditions: Breast Diseases, Breast Neoplasms, Dalpiciclib, Endocrine Breast Diseases, CDK4/6 Inhibitor, HR+/HER2- Breast CancerView official trial listing → -
Recruiting NCT NCT07671885
Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)
Not yet reported Tokyo Women's Medical University 950 participants Est. completion 2039-01-27 49 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery
Not yet reported Fudan University 636 participants Est. completion 2036-06 1 site Stand-aloneOther conditions: Ductal Carcinoma In Situ, DCISView official trial listing → -
Recruiting NCT NCT07829380
The Cardiovascular-Cognitive Health Initiative
Not yet reported National Heart Centre Singapore 5000 participants Est. completion 2030-12 4 sitesOther conditions: Cognitive ImpairmentView official trial listing → -
Recruiting NCT NCT07895511
A Study of Skipping Radiation Therapy in People With Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 136 participants Est. completion 2031-10-16 7 sites Stand-aloneOther conditions: HER2-positive Breast Cancer, Breast CancerView official trial listing → -
Completed NCT NCT00000529
Tamoxifen Study
Not yet reported NSABP Foundation Inc Est. completion 1995-11Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Hypertension, Myocardial IschemiaView official trial listing → -
Completed NCT NCT00001378
A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
Not yet reported National Cancer Institute (NCI) 75 participants Est. completion 2000-11 1 siteOther conditions: Breast Cancer, Breast NeoplasmsView official trial listing → -
Completed NCT NCT00001436
A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
Not yet reported National Cancer Institute (NCI) 24 participants Est. completion 2000-09 1 siteObstructive sleep apnea Other conditions: Neoplasm MetastasisView official trial listing → -
Completed NCT NCT00001504
A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients
Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2002-01 1 siteOther conditions: Breast Cancer, Breast NeoplasmView official trial listing → -
Completed NCT NCT00001848
The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612 participants Est. completion 2006-01 1 siteOther conditions: Endometriosis, Pelvic PainView official trial listing → -
Completed NCT NCT00002528
Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 473 participants Est. completion 2010-08 21 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002529
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 452 participants Est. completion 2010-08 20 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002580
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
Not yet reported Scottish Cancer Therapy Network 1000 participants 10 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002581
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
Not yet reported Scottish Cancer Therapy Network 1000 participants 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002582
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 6000 participants Est. completion 2007-04 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002595
Toremifene in Treating Patients With Desmoid Tumors
Not yet reported Advocate Lutheran General Hospital 72 participants Est. completion 2010-09 1 siteOther conditions: Desmoid TumorView official trial listing → -
Completed NCT NCT00002608
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Not yet reported Ottawa Regional Cancer Centre 30 participants Est. completion 2005-04 1 siteOther conditions: Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Head and Neck Cancer, Liver Cancer, Malignant Mesothelioma, Pheochromocytoma, SarcomaView official trial listing → -
Completed NCT NCT00002644
Tamoxifen for the Prevention of Breast Cancer in High-Risk Women
Not yet reported Queen Mary University of London 7154 participants Est. completion 2011-03-30 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002679
Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
Not yet reported Yale University 89 participants Est. completion 2002-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002720
Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer
Not yet reported European Institute of Oncology 642 participants Est. completion 2012-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002777
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 342 participants 48 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002784
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 344 participants Est. completion 2011-12 11 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002864
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Not yet reported NCIC Clinical Trials Group 667 participants Est. completion 2010-04-23 40 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00002920
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Not yet reported SWOG Cancer Research Network 313 participants Est. completion 2009-12 122 sites Stand-aloneOther conditions: Breast Cancer, Endometrial CancerView official trial listing → -
Completed NCT NCT00002967
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Not yet reported NSABP Foundation Inc Est. completion 2006-03 108 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00003016
Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
Not yet reported University of Oxford 20000 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003032
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Not yet reported NCIC Clinical Trials Group 224 participants Est. completion 2008-12-15 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003035
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
Not yet reported Georgetown University 40 participants Est. completion 2001-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003050
Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer
Not yet reported University of Southern California 46 participants Est. completion 2000-03 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003080
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer
Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-05 1 siteOther conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT00003099
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2003-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003140
Letrozole After Tamoxifen in Treating Women With Breast Cancer
Not yet reported NCIC Clinical Trials Group 5187 participants Est. completion 2003-10 57 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003199
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast CancerView official trial listing → -
Status unknown NCT NCT00003418
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Not yet reported International Collaborative Cancer Group 4400 participants 3 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00003678
Tamoxifen in Treating Women With Breast Cancer
Not yet reported University Hospital Birmingham 20000 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00003679
Combination Chemotherapy in Treating Women With Breast Cancer
Not yet reported Scottish Cancer Therapy Network 350 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00003680
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
Not yet reported Scottish Cancer Therapy Network 300 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003857
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Not yet reported Radiation Therapy Oncology Group 636 participants Est. completion 2022-05-20 369 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00003865
Toremifene in Treating Patients With Ovarian Cancer
Not yet reported George Washington University Est. completion 2017-02-22 1 siteOther conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT00003953
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Not yet reported Case Comprehensive Cancer Center 39 participants Est. completion 2013-01 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00003972
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
Not yet reported Fred Hutchinson Cancer Center 280 participants Est. completion 2003-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00004125
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Not yet reported Eastern Cooperative Oncology Group Est. completion 2016-11 48 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00004205
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 8028 participants Est. completion 2016-06-30 3 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00004915
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
Not yet reported Northwestern University Est. completion 2000-02 1 siteOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00005605
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
Northwestern University 79 participants Est. completion 2005-10 1 siteOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00005822
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Not yet reported Case Comprehensive Cancer Center 21 participants Est. completion 2003-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00005886
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
Not yet reported University of Kansas Medical Center Est. completion 2002-08 9 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00005908
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Breast Cancer, Breast NeoplasmView official trial listing → -
Status unknown NCT NCT00006030
Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer
Not yet reported British Association of Surgical Oncology: Breast Group 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00006369
ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00007904
Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
Not yet reported Case Comprehensive Cancer Center 16 participants Est. completion 2012-09 3 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00009997
Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
Not yet reported NYU Langone Health 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00010322
Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported Intarcia Therapeutics Est. completion 2001-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00014638
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Not yet reported Novartis Est. completion 2002-03 20 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00016276
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Not yet reported National Cancer Institute (NCI) 396 participants 1 site Stand-aloneOther conditions: Cardiac Toxicity, Inflammatory Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast CancerView official trial listing → -
Terminated NCT NCT00016341
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
Not yet reported Gynecologic Oncology Group 50 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT00016432
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Not yet reported NSABP Foundation Inc 1598 participants Est. completion 2011-02 162 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00019500
Raloxifene in Preventing Breast Cancer in Premenopausal Women
Not yet reported National Cancer Institute (NCI) Est. completion 2005-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00024336
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
Not yet reported Children's Cancer and Leukaemia Group 22 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Completed NCT NCT00026286
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Not yet reported Eastern Cooperative Oncology Group Est. completion 2007-06-15 24 sitesOther conditions: Breast Cancer, Hot Flashes, Menopausal SymptomsView official trial listing → -
Completed NCT NCT00026585
Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder
Not yet reported National Institute of Mental Health (NIMH) 50 participants Est. completion 2007-11-02 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00028353
A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
Not yet reported GTx 500 participants Est. completion 2003-07 25 sitesOther conditions: Prostatic Intraepithelial NeoplasiaView official trial listing → -
Completed NCT NCT00030147
Raloxifene and Rimostil for Perimenopause-Related Depression
Not yet reported National Institute of Mental Health (NIMH) 65 participants Est. completion 2015-06 1 siteOther conditions: Perimenopausal Depression, DepressionView official trial listing → -
Completed NCT NCT00031720
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Not yet reported Alliance for Clinical Trials in Oncology 112 participants Est. completion 2013-11 14 sites Stand-aloneOther conditions: Breast Cancer, Hot Flashes, Hot FlushesView official trial listing → -
Completed NCT NCT00031811
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Not yet reported OHSU Knight Cancer Institute 80 participants Est. completion 2003-04 1 siteOther conditions: Breast Cancer, Menopausal Symptoms, OsteoporosisView official trial listing → -
Completed NCT NCT00031850
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 150 participants Est. completion 2007-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00032136
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Not yet reported Cancer Research Campaign Clinical Trials Centre 4400 participants Est. completion 2009-04 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00033683
Combination Chemotherapy in Treating Women With Resected Breast Cancer
Not yet reported Institute of Cancer Research, United Kingdom 69 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00035256
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Not yet reported Eli Lilly and Company 330 participants Est. completion 2005-07 5 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00038103
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Not yet reported Pfizer 111 participants Est. completion 2008-03 20 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00038467
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
Not yet reported Pfizer 4740 participants Est. completion 2013-03 377 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00041080
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Not yet reported National Cancer Institute (NCI) 139 participants Est. completion 2011-01 1 site Stand-aloneOther conditions: Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial CancerView official trial listing → -
Completed NCT NCT00046137
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Not yet reported Eli Lilly and Company 13 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00047099
Combination Chemotherapy in Treating Women With Breast Cancer
Not yet reported Ludwig-Maximilians - University of Munich 446 participants Est. completion 2012-03 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00052728
Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) Est. completion 2006-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00053339
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology Stand-aloneOther conditions: Stage IV Breast Cancer, Recurrent Breast CancerView official trial listing → -
Completed NCT NCT00053898
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Not yet reported NSABP Foundation Inc 3104 participants Est. completion 2016-05 740 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00065767
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2005-03 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00066690
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 3066 participants Est. completion 2024-11-06 500 sites Stand-aloneOther conditions: Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast CancerView official trial listing → -
Terminated NCT NCT00066807
Premenopausal Endocrine Responsive Chemotherapy Trial
Not yet reported ETOP IBCSG Partners Foundation 29 participants Est. completion 2006-12 6 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00072462
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
Not yet reported Queen Mary University of London 2980 participants Est. completion 2021-05-31 97 sitesOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00083044
Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy
Northwestern University Est. completion 2008-07 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00086749
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
Northwestern University 53 participants Est. completion 2007-12 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00096369
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Not yet reported University of Texas Southwestern Medical Center 130 participants Est. completion 2007-03-15 4 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sitesOther conditions: Breast Neoplasms, Neoplasms, Hormone-DependentView official trial listing → -
Completed NCT NCT00106691
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
Not yet reported GTx 1589 participants Est. completion 2010-02 138 sitesOther conditions: Preneoplastic Conditions, Prostatic Intraepithelial NeoplasiaView official trial listing → -
Completed NCT NCT00107263
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Not yet reported Alliance for Clinical Trials in Oncology 558 participants Est. completion 2012-08Other conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00108069
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
Not yet reported National Cancer Institute (NCI) 43 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: GliomaView official trial listing → -
Completed NCT NCT00118157
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen
Not yet reported National Cancer Institute (NCI) 19 participants Est. completion 2014-09 2 sites Stand-aloneOther conditions: Estrogen Receptor Positive, Male Breast Carcinoma, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
Not yet reported National Cancer Institute (NCI) 226 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast CancerView official trial listing → -
Status unknown NCT NCT00126464
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
Not yet reported Cedars-Sinai Medical Center 100 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00149604
AFTER: Altering Fat Through Estrogen and Raloxifene
Not yet reported National Institute on Aging (NIA) 108 participants Est. completion 2006-02 1 siteOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00152178
The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
Not yet reported Taiho Pharmaceutical Co., Ltd. 680 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00163137
Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss
Not yet reported Ligand Pharmaceuticals 540 participants Est. completion 2005-10 72 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00165308
Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Not yet reported Dana-Farber Cancer Institute 29 participants Est. completion 2009-06 2 sites Stand-aloneOther conditions: Hodgkin's Disease, Breast CancerView official trial listing → -
Completed NCT NCT00174707
Study of Docetaxel in Breast Cancer Patients
Not yet reported Sanofi 998 participants Est. completion 2007-12 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Terminated NCT NCT00183963
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
Not yet reported University of Southern California 4 participants Est. completion 2008-06 1 siteOther conditions: Breast CarcinomaView official trial listing → -
Completed NCT NCT00189358
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
Not yet reported AGO Study Group 1 siteOther conditions: Ovarian Cancer, Cancer of the Fallopian Tube, Peritoneal CancerView official trial listing → -
Completed NCT NCT00190593
Raloxifene Use for The Heart
Not yet reported Eli Lilly and Company 10000 participants Est. completion 2005-11 1 siteCardiovascular disease Other conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00191425
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Not yet reported Eli Lilly and Company 810 participants Est. completion 2005-11 1 siteOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Completed NCT NCT00201851
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Not yet reported International Breast Cancer Research Foundation 740 participants Est. completion 2013-05 9 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00206466
Biologic Correlative Taxotere/AC
Not yet reported Baylor Breast Care Center 70 participants Est. completion 2012-01 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00206492
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
Not yet reported Baylor Breast Care Center 3 participants Est. completion 2006-10 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00210028
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
Not yet reported Institut Claudius Regaud 40 participants Est. completion 2008-08 3 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00214110
Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2005-01 1 siteOther conditions: Amyotrophic Lateral Sclerosis (ALS)View official trial listing → -
Completed NCT NCT00228930
Tamoxifen Pharmacogenetics and Clinical Effects
National Institute of General Medical Sciences (NIGMS) 297 participants Est. completion 2007-08 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00229697
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
Not yet reported AstraZeneca 317 participants Est. completion 2015-06 55 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00232661
PROACT - Pre-Operative Arimidex Compared To Tamoxifen
Not yet reported AstraZeneca 452 participants Est. completion 2007-12 79 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00233610
Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer
Not yet reported AstraZeneca 180 participants Est. completion 2007-10 11 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00240071
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT00241449
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
Not yet reported AstraZeneca 51 participants Est. completion 2012-01 139 sitesOther conditions: Breast Cancer, MetastasisView official trial listing → -
Completed NCT NCT00246961
Arimidex Observational: Reason for and Effect of Change From Tamoxifen
AstraZeneca 200 participants 33 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00253539
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
Not yet reported The Cleveland Clinic 3 participants Est. completion 2005-04 Stand-aloneOther conditions: Breast Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)View official trial listing → -
Completed NCT NCT00272714
Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
Not yet reported ASCEND Therapeutics 146 participants Est. completion 2005-04Other conditions: Cyclic Breast Pain, Cyclic MastalgiaView official trial listing → -
Completed NCT NCT00279448
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
Not yet reported Pfizer 9779 participants Est. completion 2009-06 59 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00287534
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
Not yet reported AstraZeneca 1059 participants Est. completion 2004-09 43 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00290654
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Not yet reported Masonic Cancer Center, University of Minnesota 45 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00290745
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Not yet reported, Not yet reported University of California, San Francisco 79 participants Est. completion 2011-06-30 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00293540
Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
Not yet reported International Breast Cancer Research Foundation 249 participants Est. completion 2015-03 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00295100
Tamoxifen-MRI Study
Not yet reported University of Pennsylvania 78 participants Est. completion 2006-07 7 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00301457
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
Not yet reported Maastricht University Medical Center 1914 participants Est. completion 2022-04 67 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00305838
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
Not yet reported Mount Vernon Cancer Centre at Mount Vernon Hospital 200 participants 24 sitesOther conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity CancerView official trial listing → -
Completed NCT NCT00309491
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
Not yet reported Austrian Breast & Colorectal Cancer Study Group 2021 participants Est. completion 2000-03 Stand-aloneOther conditions: Early-stage Breast CancerView official trial listing → -
Completed NCT NCT00332553
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Not yet reported Eli Lilly and Company 150 participants Est. completion 2004-05 1 siteOther conditions: Vasomotor Symptoms, Endometrial SafetyView official trial listing → -
Completed NCT NCT00343616
Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98
Not yet reported ETOP IBCSG Partners Foundation 135 participants Est. completion 2009-05 12 sites Stand-aloneOther conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00349011
Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
Not yet reported Yale University 60 participants Est. completion 2004-03 1 siteOther conditions: MenopauseView official trial listing → -
Completed NCT NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
Not yet reported The Alfred 54 participants Est. completion 2014-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00365599
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 43 participants Est. completion 2012-08 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00367081
Treatment of Cerebral Toxoplasmosis in HIV/AIDS
Not yet reported Department of Medical Services Ministry of Public Health of Thailand 30 participants Est. completion 2004-08 1 siteOther conditions: Toxoplasmic Encephalitis, AIDSView official trial listing → -
Completed NCT NCT00368459
Raloxifene for Women With Alzheimer's Disease
Not yet reported Stanford University 42 participants Est. completion 2012-01 4 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT00369850
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
Not yet reported ETOP IBCSG Partners Foundation 458 participants Est. completion 2012-01 16 sites Stand-aloneOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00371956
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
Not yet reported Tuen Mun Hospital 114 participants Est. completion 2010-02 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00375622
Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Not yet reported Rabin Medical Center 60 participants Est. completion 2006-06 1 siteOther conditions: Hereditary Hemorrhagic TelangiectasiaView official trial listing → -
Completed NCT NCT00381927
Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development
Baystate Medical Center 80 participants Est. completion 2006-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00383422
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
Not yet reported Eli Lilly and Company 320 participants Est. completion 2008-07 21 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Status unknown NCT NCT00398489
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Not yet reported Technical University of Munich 94 participants 5 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00412022
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
Not yet reported National Cancer Institute, Naples 1294 participants Est. completion 2024-11 20 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00424164
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 20 participants Est. completion 2010-05-28 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00427700
Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Not yet reported Hospital de Clinicas de Porto Alegre 82 participants Est. completion 2009-08 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00437359
Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer
Not yet reported Japan Breast Cancer Research Network 240 participants Est. completion 2020-05 7 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Status unknown NCT NCT00440349
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Not yet reported University of Parma 38 participants Est. completion 2007-04 1 siteOther conditions: Retroperitoneal FibrosisView official trial listing → -
Status unknown NCT NCT00449514
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle
Not yet reported Shaare Zedek Medical Center 100 participants 1 siteOther conditions: InfertilityView official trial listing → -
Completed NCT NCT00482391
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 95 participants Est. completion 2011-07 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00489944
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Not yet reported San Diego Pacific Oncology & Hematology Associates 50 participants 1 siteOther conditions: Intraocular MelanomaView official trial listing → -
Status unknown NCT NCT00492505
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Not yet reported San Diego Pacific Oncology & Hematology Associates 200 participants 1 siteOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT00532246
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
Not yet reported Eli Lilly and Company 147 participants Est. completion 2003-08 5 sitesOther conditions: Osteoporosis, Post-MenopausalView official trial listing → -
Completed NCT NCT00532428
Long Term Effects of Raloxifene Treatment on Bone Quality
Not yet reported Eli Lilly and Company 31 participants Est. completion 2003-09 7 sitesOther conditions: Osteoporosis, Post-MenopausalView official trial listing → -
Status unknown NCT NCT00541086
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
Not yet reported Gruppo Italiano Mammella (GIM) 3697 participants Est. completion 2020-07 5 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00541138
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Not yet reported City of Hope Medical Center 50 participants Est. completion 2007-10 1 siteOther conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00543829
German Preoperative Adriamycin Docetaxel Study
Not yet reported GBG Forschungs GmbH 250 participants Est. completion 1999-06 Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00569543
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
University of Nebraska 27 participants Est. completion 2012-08-02 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00590785
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2015-01-13 1 site Stand-aloneOther conditions: High Risk, Breast Cancer, Positive Nodes, Cyclophosphamide, DoxorubicinView official trial listing → -
Completed NCT NCT00605267
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment
Not yet reported AstraZeneca 197 participants Est. completion 2010-12 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00637871
Casodex - Nolvadex Combination
Not yet reported AstraZeneca Est. completion 2005-08Other conditions: Gynaecomastia, Prostate CancerView official trial listing → -
Completed NCT NCT00649090
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
Not yet reported Pfizer 1549 participants Est. completion 2007-04 61 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00659373
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
Not yet reported ETOP IBCSG Partners Foundation 86 participants Est. completion 2016-04 15 sites Stand-aloneOther conditions: Breast Cancer, Fatigue, Sleep DisordersView official trial listing → -
Completed NCT NCT00667121
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic 88 participants Est. completion 2014-05-27 6 sitesOther conditions: Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00670319
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Not yet reported Eli Lilly and Company 7705 participants Est. completion 1999-09 25 sitesOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Terminated NCT NCT00684216
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
Not yet reported, Not yet reported The Netherlands Cancer Institute 10 participants Est. completion 2013-05 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00717015
Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer
National University Hospital, Singapore 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00727883
Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
AstraZeneca 190 participants Est. completion 2008-05Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00729586
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Not yet reported National Cancer Institute (NCI) 73 participants Est. completion 2017-02 108 sites Stand-aloneOther conditions: Endometrial Carcinoma, Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Uterine Corpus Cancer, Stage IIIC1 Uterine Corpus Cancer, Stage IIIC2 Uterine Corpus Cancer, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus CancerView official trial listing → -
Suspended NCT NCT00738777
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer
Not yet reported The Netherlands Cancer Institute 250 participants Est. completion 2024-06 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00749138
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy
Not yet reported Bader, Ted, M.D. 18 participants Est. completion 2009-10 1 site Stand-aloneOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00754845
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Not yet reported Canadian Cancer Trials Group 1918 participants Est. completion 2017-04-19 43 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00756717
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer
Not yet reported Loyola University 22 participants Est. completion 2011-12-21 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00761332
Back Pain in Patients With Severe Osteoporosis
Eli Lilly and Company 650 participants Est. completion 2010-12 15 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00764322
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
Not yet reported UNC Lineberger Comprehensive Cancer Center 501 participants Est. completion 2011-07-01 7 sites Stand-aloneOther conditions: Breast Cancer, Menopausal SymptomsView official trial listing → -
Completed NCT NCT00767585
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice
AstraZeneca 560 participants Est. completion 2009-06 1 siteOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00774267
Study Evaluating Changes In Mammographic Breast Density
Pfizer 507 participants Est. completion 2010-04 26 sitesOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00784680
ATAC - Quality of Life Sub-Protocol
Not yet reported AstraZeneca 308 participants Est. completion 2004-04Other conditions: Quality of LifeView official trial listing → -
Completed NCT NCT00784862
ATAC - Pharmacokinetics (PK) Sub-Protocol
Not yet reported AstraZeneca 9358 participants Est. completion 1999-03Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT00784888
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
Pfizer 344 participants Est. completion 2011-12 16 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00784940
ATAC - Bone Density Sub-Protocol
Not yet reported AstraZeneca 308 participants Est. completion 2007-04Other conditions: Bone DensityView official trial listing → -
Terminated NCT NCT00790101
Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
Not yet reported Sanofi 6 participants Est. completion 2004-10 1 siteOther conditions: Osteoporosis, PostmenopausalView official trial listing → -
Terminated NCT NCT00810706
Adjuvant Post-Tamoxifen Exemestane Trial
Not yet reported Hellenic Breast Surgeons Society 448 participants Est. completion 2005-11 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00814034
Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy
Hellenic Breast Surgeons Society 306 participants Est. completion 2011-12 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00814125
ATAC - Endometrial Sub-Protocol
Not yet reported AstraZeneca 285 participants Est. completion 2005-12Other conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00815555
CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients
Assaf-Harofeh Medical Center 500 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00827307
Zoladex Plus Tamoxifen in Breast Cancer
Not yet reported Zhejiang Cancer Hospital 100 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Mammography, Estrogen, Lipemia, Endometrium, UltrasonographyView official trial listing → -
Completed NCT NCT00847366
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
Not yet reported AEterna Zentaris 10 participants Est. completion 2012-12 Stand-aloneOther conditions: Non Small Cell Lung Cancer, Solid Tumors, Metastatic Breast Cancer, SarcomasView official trial listing → -
Terminated NCT NCT00847821
Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene
Wyeth is now a wholly owned subsidiary of Pfizer 185 participants Est. completion 2010-08 22 sitesOther conditions: PostmenopauseView official trial listing → -
Completed NCT NCT00849030
ATAC - Arimidex, Tamoxifen Alone or in Combination
Not yet reported AstraZeneca 9358 participants Est. completion 2010-04Other conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00873366
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Mayo Clinic 92 participants Est. completion 2015-09-23 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00884143
Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer
AstraZeneca 515 participants Est. completion 2010-01 3 sitesOther conditions: Post Menopausal, Breast CancerView official trial listing → -
Completed NCT NCT00886535
Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity
Milton S. Hershey Medical Center 41 participants Est. completion 2017-07-27 1 siteOther conditions: Breast Cancer, Ductal Carcinoma in SituView official trial listing → -
Status unknown NCT NCT00896155
Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients
Not yet reported Tata Memorial Hospital 260 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Pulmonary Fibrosis, Breast CancerView official trial listing → -
Status unknown NCT NCT00897065
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Massachusetts General Hospital 957 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00897091
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
SWOG Cancer Research Network 750 participants Est. completion 2007-10 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00899197
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Wake Forest University Health Sciences 2 participants Est. completion 2012-06 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00899288
Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98
Not yet reported ETOP IBCSG Partners Foundation 60 participants Est. completion 2007-07 Stand-aloneOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00900744
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Icahn School of Medicine at Mount Sinai 121 participants Est. completion 2012-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00903162
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
Not yet reported Dana-Farber Cancer Institute 17 participants Est. completion 2014-09 4 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00912548
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women
Not yet reported Korean Breast Cancer Study Group 1234 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00929591
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
Not yet reported SWOG Cancer Research Network 1558 participants Est. completion 2010-03 Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00943527
Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
Mayo Clinic 110 participants Est. completion 2012-01 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00949598
Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer
Not yet reported Institut du Cancer de Montpellier - Val d'Aurelle 177 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00963209
Tamoxifen Citrate in Patients With Breast Cancer
Not yet reported Centre Hospitalier Universitaire Vaudois 140 participants Est. completion 2013-12 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00963417
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
Not yet reported ETOP IBCSG Partners Foundation 119 participants Est. completion 2024-10-23 13 sitesOther conditions: Breast Cancer, OsteoporosisView official trial listing → -
Completed NCT NCT00965939
An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients
Vlaamse Vereniging voor Obstetrie en Gynaecologie 300 participants 12 sitesOther conditions: ER-positive Breast CancerView official trial listing → -
Completed NCT NCT00966043
Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes
Vlaamse Vereniging voor Obstetrie en Gynaecologie 158 participants Est. completion 2011-07 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00967824
Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 1683 participantsOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00973037
CYP2D6 Genotype on the Clinical Effect of Tamoxifen
Korea University Anam Hospital 922 participants Est. completion 2016-04 1 siteOther conditions: Breast Neoplasms, Tamoxifen, Genotype, CYP2D6View official trial listing → -
Completed NCT NCT00975676
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02
Not yet reported ETOP IBCSG Partners Foundation 123 participants Est. completion 2016-12 24 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00993642
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Not yet reported Tulane University Health Sciences Center Est. completion 2010-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00999921
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
Not yet reported Medical College and Hospital Kolkata 256 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Benign Breast Disease, Fibrocystic Disease of Breast, Fibroadenoma, MastalgiaView official trial listing → -
Completed NCT NCT01016665
Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
Not yet reported Federal University of São Paulo 71 participants Est. completion 2008-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01027416
Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients
Not yet reported Roswell Park Cancer Institute 59 participants Est. completion 2015-12 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01041092
Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Not yet reported Fundació Sant Joan de Déu 34 participants Est. completion 2009-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01047358
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Pfizer 206 participants Est. completion 2014-06 22 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01050634
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)
Pfizer 980 participants Est. completion 2009-04Other conditions: Post Menopausal Women With Early Breast CancerView official trial listing → -
Completed NCT NCT01073865
Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer
Not yet reported AstraZeneca 222 participants Est. completion 2017-11-20 55 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01075802
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms
Not yet reported Western Sydney Local Health District 121 participants Est. completion 2012-12 2 sites Stand-aloneOther conditions: Breast Cancer, CYP2D6 PolymorphismView official trial listing → -
Completed NCT NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Organon and Co 684815 participants Est. completion 2012-02-16Other conditions: Esophageal Cancer, Squamous Cell Carcinoma, AdenocarcinomaView official trial listing → -
Completed NCT NCT01124695
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Not yet reported ECOG-ACRIN Cancer Research Group 124 participants Est. completion 2022-12 294 sites Stand-aloneOther conditions: Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT01157026
A Pilot Clinical Trial With Tocotrienol on Breast Cancer
Not yet reported Malaysia Palm Oil Board 240 participants Est. completion 2010-01 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01166958
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
Not yet reported University of Wisconsin, Madison 26 participants Est. completion 2012-11 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01189500
Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects
Not yet reported Pfizer 30 participants Est. completion 2010-10 2 sites Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT01192308
PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)
Not yet reported Radboud University Medical Center 42 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT01194427
A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Invasive Breast CancerView official trial listing → -
Completed NCT NCT01231659
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 72 participants Est. completion 2017-04-30 7 sitesOther conditions: Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT01234532
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
Not yet reported University of Maryland, Baltimore 5 participants Est. completion 2017-05 1 siteOther conditions: Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast CancerView official trial listing → -
Terminated NCT NCT01239745
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
Pfizer 46 participants Est. completion 2011-10 11 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01257581
Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Not yet reported Nazem Atassi 60 participants Est. completion 2013-02 9 sites Stand-aloneOther conditions: Amyotrophic Lateral SclerosisView official trial listing → -
Status unknown NCT NCT01266213
Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
Not yet reported Samsung Medical Center 147 participants Est. completion 2019-12 1 siteOther conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor, Breast Cancer Nos PremenopausalView official trial listing → -
Active, not recruiting NCT NCT01272037
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Not yet reported National Cancer Institute (NCI) 5018 participants Est. completion 2027-01-08 1568 sites Stand-aloneOther conditions: Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Synchronous Bilateral Breast CarcinomaView official trial listing → -
Completed NCT NCT01272570
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
University of Michigan 58 participants Est. completion 2013-08 1 siteOther conditions: Breast Cancer, XerostomiaView official trial listing → -
Completed NCT NCT01273168
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Not yet reported National Cancer Institute (NCI) 40 participants Est. completion 2025-12-19 1 site Stand-aloneOther conditions: Hormone Receptor-Positive Breast, Gynecologic, Desmoid, Hormone Receptor-Positive NeoplasmsView official trial listing → -
Completed NCT NCT01293032
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Not yet reported Virginia Commonwealth University 59 participants Est. completion 2016-03 8 sites Stand-aloneOther conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast CancerView official trial listing → -
Withdrawn NCT NCT01297231
Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI
Memorial Sloan Kettering Cancer Center Est. completion 2014-02Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT01298713
Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
Not yet reported ARCAGY/ GINECO GROUP 111 participants Est. completion 2018-09-12 1 site Stand-aloneOther conditions: Breast Neoplasms, mTor ProteinView official trial listing → -
Completed NCT NCT01334996
Use of Tamoxifen in Systemic Mastocytosis
Mayo Clinic 1 participants Est. completion 2019-08-28 1 siteOther conditions: Systemic MastocytosisView official trial listing → -
Completed NCT NCT01341171
The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
University of Vermont 30 participants Est. completion 2018-10 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01352091
Adjuvant AI Combined With Zoladex
Not yet reported Fudan University 670 participants Est. completion 2018-04 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT01357772
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
Not yet reported Andrea DeCensi 500 participants Est. completion 2028-12-31 14 sites Stand-aloneOther conditions: Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical HyperplasiaView official trial listing → -
Completed NCT NCT01384526
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
University of California, San Francisco 266 participants Est. completion 2015-03 1 siteOther conditions: Breast Cancer, FertilityView official trial listing → -
Completed NCT NCT01393990
A Study of LY2228820 in Participants With Advanced Cancer
Not yet reported Eli Lilly and Company 89 participants Est. completion 2013-12-14 2 sites Stand-aloneOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT01419197
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Not yet reported Hoffmann-La Roche 602 participants Est. completion 2015-08 184 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01503905
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600 participants Est. completion 2021-12 17 sitesOther conditions: Breast Cancer Nos PremenopausalView official trial listing → -
Completed NCT NCT01535027
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
Not yet reported Medical University of Vienna 125 participants Est. completion 2012-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT01563211
Predictive Model of Therapy Outcomes in Breast Cancer Patients
Imperial College London 70 participants Est. completion 2014-08 1 siteOther conditions: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.View official trial listing → -
Completed NCT NCT01564056
Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
Not yet reported UNICANCER 1989 participants Est. completion 2026-04 84 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01573637
Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Not yet reported Fundació Sant Joan de Déu 78 participants Est. completion 2014-07 3 sitesOther conditions: Schizophrenia in Post Menopausal WomenView official trial listing → -
Status unknown NCT NCT01579734
Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users
Not yet reported European Institute of Oncology 1884 participants Est. completion 2023-12 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT01612728
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
Not yet reported Baylor Breast Care Center Est. completion 2014-10Other conditions: Breast Cancer, Arthralgia, Joint PainView official trial listing → -
Completed NCT NCT01612871
Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer
Not yet reported Institut Claudius Regaud 39 participants Est. completion 2016-01-28 2 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01614210
Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
Not yet reported University of Utah 52 participants Est. completion 2016-11 1 site Stand-aloneOther conditions: Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast CancerView official trial listing → -
Status unknown NCT NCT01622361
Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01638247
Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
Not yet reported GBG Forschungs GmbH 56 participants Est. completion 2018-05 1 site Stand-aloneOther conditions: Male Breast CancerView official trial listing → -
Terminated NCT NCT01685255
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Not yet reported Incyte Corporation 83 participants Est. completion 2014-10-23 49 sitesOther conditions: Ovarian Cancer, Genitourinary (GU) TumorsView official trial listing → -
Completed NCT NCT01702610
Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 50 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Glioblastoma MutliformeView official trial listing → -
Completed NCT NCT01712893
Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer
Not yet reported Fudan University 216 participants Est. completion 2017-08 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01745289
Long-term Anastrozole Versus Tamoxifen Treatment Effects
Queen Mary University of London 2671 participants Est. completion 2017-05 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT01758146
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 412 participants Est. completion 2020-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01821066
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
Not yet reported Pfizer 25 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01937052
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 329 participants Est. completion 2024-11-25 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01950182
Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer
Not yet reported Sun Yat-sen University 392 participants Est. completion 2020-05-31 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01971515
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
Not yet reported EMD Serono 101 participants Est. completion 2018-08-09 15 sites Stand-aloneOther conditions: Solid TumorView official trial listing → -
Completed NCT NCT02040857
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Not yet reported Dana-Farber Cancer Institute 162 participants Est. completion 2024-12-27 10 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT02057133
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Not yet reported Eli Lilly and Company 198 participants Est. completion 2026-12 13 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02058381
A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2018-06-19 15 sites Stand-aloneOther conditions: Pre-menopausal Breast Cancer, PI3K Pathway InhibitionView official trial listing → -
Terminated NCT NCT02089386
Tamoxifen to Treat Barrett's Metaplasia
Not yet reported Washington University School of Medicine 7 participants Est. completion 2016-06-21 1 site Stand-aloneOther conditions: Barrett MetaplasiaView official trial listing → -
Status unknown NCT NCT02089854
Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Not yet reported Peking Union Medical College Hospital 800 participants 1 siteOther conditions: Female Breast CancerView official trial listing → -
Status unknown NCT NCT02094495
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
National Cancer Center, Korea 300 participants Est. completion 2017-03 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02097459
Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Not yet reported Peking Union Medical College Hospital 600 participants 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02101788
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 260 participants Est. completion 2025-10-27 501 sitesOther conditions: Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma, Ovarian Serous Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Serous AdenocarcinomaView official trial listing → -
Status unknown NCT NCT02132000
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
Not yet reported, Not yet reported Fengxi Su 3036 participants Est. completion 2020-05 1 site Stand-aloneOther conditions: Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor PositiveView official trial listing → -
Status unknown NCT NCT02132390
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Not yet reported Peking Union Medical College Hospital 300 participants 1 siteOther conditions: Breast Cancer, Chemotherapy Induced Amenorrhea, Ovarian Function SuppressionView official trial listing → -
Completed NCT NCT02166944
Tamoxifen Treatment in Patients With Motor Neuron Disease
Not yet reported, Not yet reported Taipei Medical University Shuang Ho Hospital 20 participants Est. completion 2019-09-18 1 site Stand-aloneOther conditions: Amyotrophic Lateral Sclerosis, ALS Functional Ration Scale, TAR-DNA-binding Protein-43, Tamoxifen, mTORView official trial listing → -
Completed NCT NCT02188745
ER Reactivation Therapy for Breast Cancer
Not yet reported Dartmouth-Hitchcock Medical Center 20 participants Est. completion 2024-07-05 3 sites Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02197897
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Not yet reported Baylor College of Medicine 15 participants Est. completion 2019-06-28 2 sites Stand-aloneOther conditions: Bladder CancerView official trial listing → -
Completed NCT NCT02206984
Endocrine Response in Women With Invasive Lobular Breast Cancer
Not yet reported Priscilla McAuliffe 201 participants Est. completion 2024-07-19 12 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02269670
Phase II Study of Everolimus Beyond Progression
Not yet reported Emory University 3 participants Est. completion 2021-01-25 3 sites Stand-aloneOther conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast CancerView official trial listing → -
Completed NCT NCT02271282
Estradiol-Receptor Blockade in Older Men and Women
Not yet reported Mayo Clinic 40 participants Est. completion 2016-05 1 siteOther conditions: Normal Healthy VolunteersView official trial listing → -
Completed NCT NCT02278120
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 672 participants Est. completion 2023-04-20 183 sites Stand-aloneOther conditions: Advanced Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02285179
Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Not yet reported, Not yet reported The Netherlands Cancer Institute 189 participants Est. completion 2022-05-01 14 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02291913
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2019-01-31 8 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02311647
Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients
Sheba Medical Center 120 participants Est. completion 2017-02 1 siteOther conditions: Endometrial Receptivity Post Tamoxifen ExposureView official trial listing → -
Status unknown NCT NCT02313051
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 200 participants Est. completion 2017-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02333370
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2022-09-29 15 sites Stand-aloneOther conditions: Hormone Receptor Positive, HER2-negative, Advanced Breast CancerView official trial listing → -
Completed NCT NCT02344550
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
Not yet reported Asan Medical Center 137 participants Est. completion 2018-10 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02344940
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
Not yet reported Shanghai Jiao Tong University School of Medicine 104 participants Est. completion 2018-08 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02353429
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 25 participants Est. completion 2015-12 1 siteOther conditions: Desmoid Type-fibromatosisView official trial listing → -
Completed NCT NCT02354001
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Not yet reported The Alfred 80 participants Est. completion 2019-01 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT02355600
Oocyte Recovery During Tamoxifen Adjuvant Therapy
Instituto de Investigacion Sanitaria La Fe 20 participants Est. completion 2020-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02366130
Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer
Not yet reported M.D. Anderson Cancer Center 45 participants Est. completion 2020-12-16 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02382094
Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy
Not yet reported Karolinska University Hospital 110 participants Est. completion 2012-07 Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02384239
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Not yet reported University of California, San Francisco 70 participants Est. completion 2021-01-31 9 sites Stand-aloneOther conditions: Metastatic Breast Cancer, Hormone Receptor PositiveView official trial listing → -
Terminated NCT NCT02395627
Reversing Therapy Resistance With Epigenetic-Immune Modification
Not yet reported University of California, San Francisco 38 participants Est. completion 2019-06-08 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02404844
Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer
Not yet reported University Hospital, Essen 48 participants Est. completion 2017-10-19 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02479256
Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs
Not yet reported Ain Shams University 600 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: PCOSView official trial listing → -
Completed NCT NCT02480218
Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women
Sunnybrook Health Sciences Centre 47 participants Est. completion 2017-06 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02488603
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
Not yet reported National Cancer Center, Korea 360 participants Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02506790
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
Not yet reported N.N. Petrov National Medical Research Center of Oncology 96 participants Est. completion 2022-08 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02513329
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Not yet reported Northwestern University 37 participants Est. completion 2020-01 1 siteOther conditions: Hot Flushes, Hot FlashesView official trial listing → -
Status unknown NCT NCT02513849
Tamoxifen in Patients With Oesophageal Cancer
Not yet reported University of Nottingham 20 participants Est. completion 2018-11 2 sites Stand-aloneOther conditions: Cancer, Gastrointestinal NeoplasmsView official trial listing → -
Completed NCT NCT02517593
Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake
Not yet reported, Not yet reported Mayo Clinic 151 participants Est. completion 2019-12-01 2 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02584465
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
Not yet reported ARCAGY/ GINECO GROUP 68 participants Est. completion 2021-09-19 21 sitesOther conditions: Ovarian CarcinomaView official trial listing → -
Active, not recruiting NCT NCT02603679
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
Not yet reported Thomas Hatschek 181 participants Est. completion 2031-12-31 3 sites Stand-aloneOther conditions: Early-Stage Breast Carcinoma, Estrogen Receptor Positive TumorView official trial listing → -
Completed NCT NCT02630693
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Not yet reported Canadian Cancer Trials Group 180 participants Est. completion 2023-11-29 22 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02654093
A Drug-drug Interaction Study of DP-R213
Not yet reported Alvogen Korea 24 participants Est. completion 2016-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02668666
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Not yet reported Oana Danciu, MD 49 participants Est. completion 2023-10-24 7 sites Stand-aloneOther conditions: Hormone Receptor Positive Malignant Neoplasm of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT02690870
Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 210 participants Est. completion 2019-03 Stand-aloneOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02753686
Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sitesOther conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerView official trial listing → -
Completed NCT NCT02762643
DP-R213 Pharmacokinetics Study
Not yet reported Alvogen Korea 61 participants Est. completion 2016-08Other conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT02764541
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Not yet reported Dana-Farber Cancer Institute 195 participants Est. completion 2031-04 11 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02788201
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2019-10-23 1 site Stand-aloneOther conditions: Urothelial Carcinoma, Bladder Cancer, Urinary Bladder NeoplasmsView official trial listing → -
Status unknown NCT NCT02801786
TAmoxifen Versus LIdocaine Cream. A Randomized Clinical Trial for Reducing Pain and Discomfort During Mammography
Not yet reported, Not yet reported Universidade Federal de Goias 450 participants Est. completion 2021-06 1 site Stand-aloneOther conditions: Pain, DiscomfortView official trial listing → -
Completed NCT NCT02806544
Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country
Not yet reported Vanderbilt University 35 participants Est. completion 2014-09 Stand-aloneOther conditions: Breast Cancer, Breast NeoplasmsView official trial listing → -
Terminated NCT NCT02819921
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Not yet reported Seoul National University Hospital 59 participants Est. completion 2019-06-15 3 sitesOther conditions: Hot Flashes, Breast NeoplasmsView official trial listing → -
Completed NCT NCT02824224
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Not yet reported Oregon Health and Science University 42 participants Est. completion 2018-01-08 1 site Stand-aloneOther conditions: Menorrhagia, Metrorrhagia, Medicated Intrauterine DevicesView official trial listing → -
Completed NCT NCT02835079
Treatment Effect of Tamoxifen on Patients With DMD
Not yet reported Hadassah Medical Organization 19 participants Est. completion 2020-11Other conditions: Duchenne Muscular DystrophyView official trial listing → -
Completed NCT NCT02866955
Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.
Not yet reported Institut de Cancérologie de Lorraine 100 participants Est. completion 2015-08-28 21 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02903121
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
Not yet reported Oregon Health and Science University 109 participants Est. completion 2019-06-05 1 site Stand-aloneOther conditions: Bleeding, Implants, Breakthrough BleedingView official trial listing → -
Status unknown NCT NCT02914158
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
Not yet reported First Affiliated Hospital, Sun Yat-Sen University 680 participants Est. completion 2025-12 25 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02936206
Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.
Not yet reported Icahn School of Medicine at Mount Sinai 2 participants Est. completion 2020-05-01 3 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02970682
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
Not yet reported Evgen Pharma 60 participants Est. completion 2019-03 10 sites Stand-aloneOther conditions: Breast NeoplasmView official trial listing → -
Status unknown NCT NCT02977949
The Effects of Seasonal Changes in Osteoporosis Treatment
Toshihiko Kono 200 participants Est. completion 2019-12 1 siteOther conditions: Selective Estrogen Receptor Modulator (SERM)View official trial listing → -
Completed NCT NCT02979301
Impact of Low-dose Tamoxifen on BPU
Not yet reported Mayo Clinic 22 participants Est. completion 2018-11-01 1 site Stand-aloneOther conditions: High Background Uptake on MBIView official trial listing → -
Completed NCT NCT02982083
Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis
Not yet reported Sara Saeidi Shahri 34 participants Est. completion 2020-09Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02988986
TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer
Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2019-03-30 3 sites Stand-aloneOther conditions: Estrogen Receptor Positive Breast CancerView official trial listing → -
Completed NCT NCT02993159
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Not yet reported Northwestern University 100 participants Est. completion 2022-01-24 6 sitesOther conditions: Ductal Breast Carcinoma In Situ, Estrogen Receptor PositiveView official trial listing → -
Completed NCT NCT02995772
Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Not yet reported Dharmais National Cancer Center Hospital 122 participants Est. completion 2018-11 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03006003
Osteoporosis Treatment in Post-menopausal Women
Not yet reported Taichung Veterans General Hospital 500 participants Est. completion 2021-12 2 sitesOther conditions: Depressive SyndromeView official trial listing → -
Completed NCT NCT03010267
DP-R213 Phase 1 Pharmacokinetics Study
Not yet reported Alvogen Korea 46 participants Est. completion 2017-03-29Other conditions: HealthyView official trial listing → -
Completed NCT NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Not yet reported Iris Sommer 110 participants Est. completion 2021-07-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOSView official trial listing → -
Completed NCT NCT03045653
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer
Not yet reported Sun Yat-sen University 30 participants Est. completion 2019-02-21 1 site Stand-aloneOther conditions: Breast Cancer MetastaticView official trial listing → -
Withdrawn NCT NCT03058939
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
Not yet reported University of Chicago Est. completion 2019-06 1 siteOther conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage IIIView official trial listing → -
Status unknown NCT NCT03060304
The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.
Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-06 Stand-aloneOther conditions: EndometriumView official trial listing → -
Completed NCT NCT03063619
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
Not yet reported M.D. Anderson Cancer Center 194 participants Est. completion 2021-10-26 5 sitesOther conditions: Mammographically Dense BreastView official trial listing → -
Completed NCT NCT03065621
Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)
Not yet reported Jules Bordet Institute 100 participants Est. completion 2023-02-01 5 sites Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Withdrawn NCT NCT03081234
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer
Not yet reported Novartis Pharmaceuticals Est. completion 2025-11-17 Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03112031
Treatment With Tamoxifen in Cryptococcal Meningitis
Not yet reported Oxford University Clinical Research Unit, Vietnam 50 participants Est. completion 2018-07-17 3 sites Stand-aloneOther conditions: Meningitis Streptococcal, Hiv, Meningitis, MeningoencephalitisView official trial listing → -
Status unknown NCT NCT03137368
A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300 participants Est. completion 2023-10-30 1 siteOther conditions: CYP2D6 PolymorphismView official trial listing → -
Withdrawn NCT NCT03147196
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Not yet reported Mayo Clinic Est. completion 2022-06Other conditions: Stage I Prostate Adenocarcinoma, Stage II Prostate AdenocarcinomaView official trial listing → -
Active, not recruiting NCT NCT03161353
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
Not yet reported MedSIR 377 participants Est. completion 2026-11-01 56 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03184090
Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC
Not yet reported MedSIR 33 participants Est. completion 2020-10-27 15 sites Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT03199963
Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue
Not yet reported BHR Pharma, LLC 223 participants Est. completion 2019-04-23 19 sites Stand-aloneOther conditions: Mammographic Breast DensityView official trial listing → -
Completed NCT NCT03219476
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
Not yet reported Medical College of Wisconsin 37 participants Est. completion 2025-03-20 1 site Stand-aloneOther conditions: Breast Cancer, Invasive Breast CancerView official trial listing → -
Completed NCT NCT03229499
Pulmonary Hypertension and Anastrozole Trial
Not yet reported University of Pennsylvania 84 participants Est. completion 2022-07-22 7 sites Stand-aloneOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Completed NCT NCT03272477
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
Not yet reported Palleos Healthcare GmbH 257 participants Est. completion 2024-03-04 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT03280563
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 144 participants Est. completion 2024-09-26 22 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT03354039
Tamoxifen in Duchenne Muscular Dystrophy
Not yet reported University Hospital, Basel, Switzerland 93 participants Est. completion 2022-10-18 11 sites Stand-aloneOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Completed NCT NCT03355157
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT03381963
Hemostatic Profiles of Endocrine Therapies for Breast Cancer
University Hospital, Geneva 100 participants Est. completion 2020-02-28 1 siteOther conditions: Breast Neoplasms, Venous ThromboembolismView official trial listing → -
Completed NCT NCT03382834
Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 31 participants Est. completion 2023-07-27 15 sites Stand-aloneOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT03418831
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
Not yet reported Shanghai Mental Health Center 45 participants Est. completion 2019-07-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Not yet reported National Cancer Center, Japan 180 participants Est. completion 2025-09 23 sites Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT03493854
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
Not yet reported Hoffmann-La Roche 500 participants Est. completion 2023-06-02 107 sites Stand-aloneOther conditions: Early Breast CancerView official trial listing → -
Status unknown NCT NCT03504631
Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen
Trisakti University 117 participants Est. completion 2018-12-01 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT03528902
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
Not yet reported Vanderbilt University Medical Center 18 participants Est. completion 2023-06-14 1 site Stand-aloneOther conditions: Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension, Lung Diseases, Tamoxifen, Estrogen Receptor Antagonist, Hormone Antagonists, EstrogensView official trial listing → -
Active, not recruiting NCT NCT03573648
Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33 participants Est. completion 2027-03-30 4 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03582865
Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Assiut University 100 participants Est. completion 2020-12Other conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT03623633
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Not yet reported Massachusetts General Hospital 51 participants Est. completion 2023-08-01 1 siteOther conditions: Osteoporosis, Postmenopausal, OsteoporosisView official trial listing → -
Status unknown NCT NCT03664895
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Not yet reported Seoul National University Hospital 224 participants Est. completion 2024-12-31 1 siteOther conditions: Breast Cancer InvasiveView official trial listing → -
Completed NCT NCT03691493
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Not yet reported Emory University 36 participants Est. completion 2022-10-13 10 sites Stand-aloneOther conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8View official trial listing → -
Active, not recruiting NCT NCT03707340
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
Not yet reported Memorial Sloan Kettering Cancer Center 43 participants Est. completion 2027-10-14 7 sitesOther conditions: Breast Cancer, Hyposexual Desire DisorderView official trial listing → -
Completed NCT NCT03715413
Analgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia
Not yet reported Mansoura University 64 participants Est. completion 2018-12-01 1 siteOther conditions: Breast FibroadenomaView official trial listing → -
Completed NCT NCT03719495
Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer
Duke University 68 participants Est. completion 2023-07-31 1 siteOther conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HealthyView official trial listing → -
Completed NCT NCT03764462
Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers
Not yet reported Addpharma Inc. 52 participants Est. completion 2019-02-08 1 siteOther conditions: OsteoporosisView official trial listing → -
Active, not recruiting NCT NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Not yet reported ETOP IBCSG Partners Foundation 405 participants Est. completion 2029-01-01 53 sites Stand-aloneOther conditions: Breast Cancer RecurrentView official trial listing → -
Completed NCT NCT03824171
Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers
Not yet reported Addpharma Inc. 52 participants Est. completion 2019-04-08 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT03844685
Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88 participants Est. completion 2016-02-23 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT03870399
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Not yet reported AC Camargo Cancer Center 23 participants Est. completion 2023-05-13 2 sites Stand-aloneOther conditions: Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive TumorView official trial listing → -
Active, not recruiting NCT NCT03879577
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
Not yet reported University of Chicago 53 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Breast Cancer, Breast Cancer Female, HER2-positive Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage IIIView official trial listing → -
Completed NCT NCT03898947
Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies
Università degli Studi dell'Insubria 1329 participants Est. completion 2019-12Other conditions: Breast Cancer, Endometrial CancerView official trial listing → -
Status unknown NCT NCT03925233
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital 300 participants Est. completion 2021-12-15 1 siteOther conditions: Breast Cancer OrganoidsView official trial listing → -
Completed NCT NCT03948568
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
Not yet reported Ottawa Hospital Research Institute 262 participants Est. completion 2022-04-09 1 siteOther conditions: Early-stage Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04009044
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Not yet reported Northwestern University 156 participants Est. completion 2026-06-25 2 sitesOther conditions: Cancer Survivor, Ductal Breast Carcinoma In Situ, Invasive Breast CarcinomaView official trial listing → -
Status unknown NCT NCT04023292
Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 185 participants Est. completion 2025-07 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT04024462
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer
Not yet reported Hoffmann-La Roche 200 participants Est. completion 2026-01-19 18 sites Stand-aloneOther conditions: HER2-positive Early Breast CancerView official trial listing → -
Withdrawn NCT NCT04038489
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
Not yet reported University of Virginia Est. completion 2023-04-30 1 site Stand-aloneOther conditions: Breast Cancer, Estrogen Receptor-positive Breast CancerView official trial listing → -
Terminated NCT NCT04059484
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
Not yet reported Sanofi 367 participants Est. completion 2025-01-02 109 sitesOther conditions: Breast Cancer MetastaticView official trial listing → -
Completed NCT NCT04080297
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Not yet reported Que Oncology 21 participants Est. completion 2014-07-28Other conditions: Vasomotor Symptoms (VMS)View official trial listing → -
Status unknown NCT NCT04116827
Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
Samsung Medical Center 20 participants Est. completion 2020-12-31 1 siteOther conditions: Sleep Disorder, Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04134598
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
Not yet reported Azienda Ospedaliero-Universitaria Careggi 926 participants Est. completion 2030-03-31 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04246606
Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer
UNICANCER 155 participants Est. completion 2023-11-01 1 siteOther conditions: Breast Neoplasm FemaleView official trial listing → -
Active, not recruiting NCT NCT04272801
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
Not yet reported Shayna Showalter, MD 84 participants Est. completion 2026-06-01 2 sites Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT04300790
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
Not yet reported MedSIR 69 participants Est. completion 2025-03-16 19 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04383275
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Not yet reported Fudan University 367 participants Est. completion 2031-07-06 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT04389424
Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer
Instituto Jalisciense de Cancerologia 300 participants Est. completion 2022-01-30 1 siteOther conditions: Breast Cancer, Endocrine Therapy, Endocrine Therapy Adverse Reaction, Vitamin D Deficiency, Nutrition Disorders, ObesityView official trial listing → -
Status unknown NCT NCT04389580
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus
Not yet reported Kafrelsheikh University 160 participants Est. completion 2021-12Other conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04433494
A Study of TY-302 in Patients With Advanced Solid Tumors
Not yet reported TYK Medicines, Inc 60 participants Est. completion 2023-12 1 site Stand-aloneOther conditions: Breast Cancer, Solid TumorView official trial listing → -
Terminated NCT NCT04460430
Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer
Not yet reported SOLTI Breast Cancer Research Group 12 participants Est. completion 2021-11-29 15 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04479098
Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors
Not yet reported Federal University of Uberlandia 14 participants Est. completion 2018-06-30 1 site Stand-aloneOther conditions: Breast Neoplasm FemaleView official trial listing → -
Status unknown NCT NCT04488107
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
Not yet reported, Not yet reported Ahon Pharmaceutical Co., Ltd. 78 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Enrolling by invitation NCT NCT04488614
Prospective Breast Cancer Biobanking
Helse Stavanger HF 1200 participants Est. completion 2030-07-15 2 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT04504331
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Not yet reported Jennifer Lee Caswell-Jin 4 participants Est. completion 2021-10-22 1 site Stand-aloneOther conditions: Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast CancerView official trial listing → -
Withdrawn NCT NCT04531748
Selective Estrogen Modulation and Melatonin in Early COVID-19
Not yet reported Reena Mehra, MD Est. completion 2022-09Other conditions: Covid19View official trial listing → -
Status unknown NCT NCT04568096
Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19
Not yet reported Kafrelsheikh University 160 participants Est. completion 2020-12Other conditions: the Lung Complication of COVID-19View official trial listing → -
Active, not recruiting NCT NCT04569747
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Not yet reported Dana-Farber Cancer Institute 393 participants Est. completion 2032-09-01 32 sitesOther conditions: HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer, Node Negative Breast Cancer, Micrometastasis Breast Cancer, Hormone Receptor Positive Breast CancerView official trial listing → -
Terminated NCT NCT04570956
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
Not yet reported Mayo Clinic 65 participants Est. completion 2024-10-15 3 sites Stand-aloneOther conditions: Breast Atypical Hyperplasia, Breast Lobular Carcinoma in Situ, Breast Atypical Lobular Hyperplasia, Breast CarcinomaView official trial listing → -
Status unknown NCT NCT04666805
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 siteOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04733118
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
Not yet reported MedSIR 393 participants Est. completion 2028-03 41 sites Stand-aloneOther conditions: Early Breast CancerView official trial listing → -
Completed NCT NCT04736693
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Brigham and Women's Hospital 18028 participants Est. completion 2021-02-18 1 siteOther conditions: OsteoporosisView official trial listing → -
Status unknown NCT NCT04891731
Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120 participants Est. completion 2023-09Other conditions: Hormone Receptor-positive Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04906395
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Not yet reported Tolmar Inc. 250 participants Est. completion 2027-01-30 59 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT04926545
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Not yet reported Guangzhou University of Traditional Chinese Medicine 24 participants Est. completion 2024-07-20 1 siteOther conditions: Malignant Tumor, DiarrheaView official trial listing → -
Withdrawn NCT NCT04933240
Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial
Not yet reported Virginia Commonwealth University Est. completion 2024-12 2 sitesOther conditions: Vaginal BleedingView official trial listing → -
Status unknown NCT NCT04961632
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Not yet reported National Cancer Centre, Singapore 75 participants Est. completion 2025-11 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Active, not recruiting NCT NCT04961996
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Not yet reported Hoffmann-La Roche 4170 participants Est. completion 2033-09-30 621 sitesOther conditions: Early Breast CancerView official trial listing → -
Status unknown NCT NCT04995731
Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer
Assiut University 328 participants Est. completion 2024-07 1 siteOther conditions: Endometrial CancerView official trial listing → -
Status unknown NCT NCT05016349
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
Not yet reported Mahmoud Ramadan mohamed Elkazzaz 160 participants Est. completion 2021-12 Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT05026073
Vibrational Spectroscopy for Endometrial Cancer Diagnosis
Nottingham University Hospitals NHS Trust 150 participants Est. completion 2024-11 1 siteOther conditions: Endometrial Cancer, Endometrial HyperplasiaView official trial listing → -
Completed NCT NCT05101564
Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer
Not yet reported Jennifer Lee Caswell-Jin 19 participants Est. completion 2024-06-03 1 site Stand-aloneOther conditions: Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast CancerView official trial listing → -
Completed NCT NCT05110170
Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
Not yet reported Luye Pharma Group Ltd. 188 participants Est. completion 2022-06-24 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05131893
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary 300 participants Est. completion 2031-12 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05133674
Therapeutic Dose Monitoring (TDM) of Tamoxifen
Not yet reported Karolinska University Hospital 40 participants Est. completion 2023-03-01 1 site Stand-aloneOther conditions: Breast Cancer, Breast Carcinoma, Breast Tumors, Cancer of Breast, Malignant Neoplasm of BreastView official trial listing → -
Completed NCT NCT05156892
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer
Not yet reported Anthony Joshua, FRACP 12 participants Est. completion 2026-11-01 1 site Stand-aloneOther conditions: Ovarian CancerView official trial listing → -
Status unknown NCT NCT05157373
The Effect of Androgen Receptor Polymorphism on Endometrial Cancer
University of Nicosia 150 participants Est. completion 2024-04-01Other conditions: Androgen Receptor Abnormal, Endometrial DisorderView official trial listing → -
Active, not recruiting NCT NCT05161195
Roll-over Study to Allow Continued Access to Ribociclib
Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2030-08-14 73 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT05172050
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Not yet reported, Not yet reported Dompé Farmaceutici S.p.A 61 participants Est. completion 2021-06-12 11 sitesOther conditions: SARS CoV 2 InfectionView official trial listing → -
Status unknown NCT NCT05200663
Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility
Not yet reported Sharif Medical Research Center 110 participants Est. completion 2022-10 1 site Stand-aloneOther conditions: Oligoasthenoteratozoospermia, Male InfertilityView official trial listing → -
Active, not recruiting NCT NCT05296798
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
Not yet reported Hoffmann-La Roche 922 participants Est. completion 2030-12-31 198 sites Stand-aloneOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT05306340
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
Not yet reported Genentech, Inc. 373 participants Est. completion 2027-06-15 136 sitesOther conditions: Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05460819
Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-07-31 1 siteOther conditions: Hot Flashes, Breast Cancer, AcupunctureView official trial listing → -
Active, not recruiting NCT NCT05463601
Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 132 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05501158
CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
Not yet reported Nalagenetics Pte Ltd 150 participants Est. completion 2024-06-30 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05524116
Telehealth Exercise and Mindfulness for Pain in Osteoarthritis
Not yet reported Boston University Charles River Campus 45 participants Est. completion 2023-07-03 1 site Stand-aloneOsteoarthritisView official trial listing → -
Status unknown NCT NCT05525481
Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
Not yet reported Erasmus Medical Center 100 participants Est. completion 2024-02-28 1 site Stand-aloneOther conditions: ER+ Breast CancerView official trial listing → -
Not yet recruiting NCT NCT05613504
Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
Not yet reported Nanjing University of Traditional Chinese Medicine 90 participants Est. completion 2027-12-01 1 siteOther conditions: Hot Flashes, Breast Cancer, AcupunctureView official trial listing → -
Enrolling by invitation NCT NCT05645536
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Not yet reported Tolmar Inc. 250 participants Est. completion 2030-03 46 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05659563
Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%
Not yet reported MedSIR 92 participants Est. completion 2025-01-30 18 sitesOther conditions: Breast Cancer, Breast Cancer, Early-OnsetView official trial listing → -
Active, not recruiting NCT NCT05780567
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 1946 participants Est. completion 2027-01 3 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT05800197
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 siteOther conditions: Breast Cancer, Neoadjuvant Endocrine TherapyView official trial listing → -
Active, not recruiting NCT NCT05826964
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
Not yet reported University of Miami 24 participants Est. completion 2030-11-30 1 site Stand-aloneOther conditions: Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT05861830
Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2026-06-30 1 site Stand-aloneOther conditions: Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT05870813
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer
Institut fuer Frauengesundheit 3000 participants Est. completion 2023-12 1 siteOther conditions: Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Status unknown NCT NCT05889871
A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer
Not yet reported Fudan University 916 participants Est. completion 2026-06-01 Stand-aloneOther conditions: HR+/HER2-breast CancerView official trial listing → -
Status unknown NCT NCT05890287
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-10-01 1 site Stand-aloneOther conditions: HR Positive HER2 Negative Advanced Breast CancerView official trial listing → -
Completed NCT NCT05908773
A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors
Not yet reported TransCode Therapeutics 1 participants Est. completion 2023-09-18 1 siteOther conditions: Advanced Solid TumorView official trial listing → -
Active, not recruiting NCT NCT06001762
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
Not yet reported Dana-Farber Cancer Institute 90 participants Est. completion 2027-01-01 12 sites Stand-aloneOther conditions: Breast Cancer, Early-stage Breast Cancer, High Risk Breast CarcinomaView official trial listing → -
Completed NCT NCT06033092
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Not yet reported European Institute of Oncology 110 participants Est. completion 2026-07-31 4 sitesOther conditions: BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ, Lobular Carcinoma in Situ, ATM Gene Mutation, CHEK2 Gene Mutation, CDH1 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene MutationView official trial listing → -
Status unknown NCT NCT06120595
Intervention Study Based on Real-world Data to Improve Quality of Life After Breast Cancer Treatment, the REBECCA-2 Study
Not yet reported Helse Stavanger HF 81 participants Est. completion 2025-05-01 1 site Stand-aloneOther conditions: Cancer Related FatigueView official trial listing → -
Status unknown NCT NCT06154590
Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
DR. DIANE CHISESI NFS. MD. PHD. 100 participants Est. completion 2026-09 1 siteOther conditions: Metastatic Breast Cancer, Tumor, Muscle Neoplasms, Chronic PainView official trial listing → -
Not yet recruiting NCT NCT06223698
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
Not yet reported Region Örebro County 3832 participants Est. completion 2035-05-02 15 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06346457
Breast Cancer & Antiestrogenic Therapy & Brain
International Research Training Group 2804 180 participants Est. completion 2026-04-01 1 siteOther conditions: Breast Cancer Female, Healthy Female, Menopause, Anti-estrogenic TherapyView official trial listing → -
Not yet recruiting NCT NCT06355401
Maintenance Hormonal Therapy and DLBCL
Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2029-03 Stand-aloneOther conditions: Diffuse Large B Cell LymphomaView official trial listing → -
Not yet recruiting NCT NCT06404775
External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 456 participants Est. completion 2030-05-16 1 site Stand-aloneOther conditions: MastalgiaView official trial listing → -
Active, not recruiting NCT NCT06440967
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sites Stand-aloneOther conditions: Hot FlashesView official trial listing → -
Active, not recruiting NCT NCT06449027
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 211 participants Est. completion 2026-03 1 site Stand-aloneOther conditions: Breast Cancer SubjectsView official trial listing → -
Active, not recruiting NCT NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Not yet reported Stemline Therapeutics, Inc. 4556 participants Est. completion 2032-10 555 sites Stand-aloneOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT06580535
Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas
Assiut University 100 participants Est. completion 2025-12Other conditions: Bipolar DisorderView official trial listing → -
Terminated NCT NCT06630325
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
Not yet reported OHSU Knight Cancer Institute 6 participants Est. completion 2026-03-11 1 site Stand-aloneOther conditions: Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Sarcoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8View official trial listing → -
Terminated NCT NCT06660030
Factors Influencing Tamoxifen Adherence in Women With Breast Cancer Receiving Tamoxifen in Botswana.
University of Pennsylvania 10 participants Est. completion 2025-11-20 1 siteOther conditions: Breast Cancer FemaleView official trial listing → -
Suspended NCT NCT06671912
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial
Not yet reported Alliance for Clinical Trials in Oncology 1556 participants Est. completion 2031-11-30 732 sites Stand-aloneOther conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In SituView official trial listing → -
Active, not recruiting NCT NCT06684587
Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B
Not yet reported Boston University Charles River Campus 66 participants Est. completion 2027-08 1 site Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT06840847
Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )
Not yet reported Canan Kas 79 participants Est. completion 2024-10-29 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT06982313
Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms
Ente Ospedaliero Ospedali Galliera 1545 participants Est. completion 2026-03-08 2 sitesOther conditions: Breast Cancer InvasiveView official trial listing → -
Completed NCT NCT07072013
An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer
Novartis Pharmaceuticals 1937 participants Est. completion 2025-04-24 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07101159
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Not yet reported Fujian Cancer Hospital 200 participants Est. completion 2031-12 Stand-aloneOther conditions: Early Breast Cancer, Adjuvant Therapy, Hormone Receptor Positive / HER2-negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07153757
De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial
Not yet reported Fudan University 2934 participants Est. completion 2033-09-01 1 site Stand-aloneOther conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)View official trial listing → -
Not yet recruiting NCT NCT07213206
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer
Not yet reported Fudan University 1500 participants Est. completion 2035-09-01Other conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07447024
Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy
Not yet reported Cairo University 60 participants Est. completion 2026-06-15 1 site Stand-aloneOther conditions: MastectomyView official trial listing → -
Not yet recruiting NCT NCT07499999
Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
Not yet reported Dana-Farber Cancer Institute 140 participants Est. completion 2028-08-31 2 sites Stand-aloneOther conditions: Breast Cancer, Ductal Carcinoma, Estrogen-receptor-positive Breast Cancer, Atypical Lobular Hyperplasia, BRCA2 Mutation, CHEK2 Gene Mutation, Ataxia Telangiectasia Mutated Gene MutationView official trial listing → -
Not yet recruiting NCT NCT07729046
Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
Not yet reported University of California, San Diego 150 participants Est. completion 2035-06 1 siteOther conditions: Metastatic Invasive Breast Cancer, Resistant Breast Cancer, ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Active, not recruiting NCT NCT07806630
SHORTened Duration of TAMoxifen
Not yet reported Rutgers, The State University of New Jersey 250 participants Est. completion 2029-07 1 site Stand-aloneOther conditions: High Risk for Invasive Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07844759
SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers
Not yet reported Renaissance Institute of Precision Oncology and Radiosurgery 30 participants Est. completion 2032-01-01 1 site Stand-aloneOther conditions: Breast Cancer, Early-Stage Breast Carcinoma, Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07859319
Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting
Not yet reported Hospices Civils de Lyon 105 participants Est. completion 2028-03 3 sites Stand-aloneOther conditions: Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint PainView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Tamoxifen Citrate, Tamoxifen, TMX
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
